Abstract
New series of quinoline derivatives were synthesized from 2-chloroquinoline-3-carbaldehydes. In the reaction sequence, substituted acetanilides were cyclized to give 2-chloroquinoline-3-carbaldehydes 2a–d, which were transformed to 6a–d, which were then cyclized to give azetidinones 9a–d. The key scaffolds viz., 2-methoxy derivatives 3a–d, obtained from 2a–d were converted to target Schiff bases 4a–d, 5a–d and azetidinones 7a–d, 8a–d in good yields. Structures of these compounds were established by FTIR, 1H NMR, 13C NMR and mass spectrometry. The compounds 4a–d to 9a–d were evaluated for in vitro antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Vibrio cholera and antitubercular activity against Mycobacterium tuberculosis H37Rv. The Schiff bases and azetidinone derivatives exhibited good antibacterial and antitubercular activities. Bacterial enoyl ACP-reductase catalyzes the final step in each cycle of bacterial fatty acid biosynthesis and is an attractive target for the development of new antimicrobial agents. Molecular docking into active site of enoyl ACP-reductase was performed on 2H7M.PDB and 4JX8.PDB files to understand ligand–protein interactions. The compounds obtained from the present research can be used as scaffolds in fragment-based design of new potent drugs.
Graphical Abstract
Molecular modeling, synthesis, spectral, antimicrobial studies of quinolinyl Schiff bases and azetidinones using crystal structure of E. coli and M. tuberculosis enoyl ACP-reductase (4JX8/2H7M PDB) and compared with in vitro antimicrobial activity.
Similar content being viewed by others
References
Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR Jr (1994) InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227–230
Bawa S, Kumar S, Drabu S, Kumar R (2009) Synthesis and antimicrobial activity of 2-chloro-6-methylquinoline hydrazone derivatives. J Pharm Bioall Sci 1:27–31
Candea ALP, Ferreira ML, Pais KC, Cardoso LNF, Kaiser CR, Henriques MGMO, Lourenco MCS, Bezerra FAFM, de Souza MVN (2009) Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Bioorg Med Chem Lett 19:6272–6274
Carta A, Briguglio I, Piras S, Corona P, Boatto G, Nieddu M, Giunchedi P, Marongiu ME, Giliberti G, Iuliano F, Blois S, Ibba C, Busonera B, La Colla P (2011) Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors. Bioorg Med Chem 19(23):7070–7084
Chen Y, Zhao Y, Lu C, Tzeng C, Wang JP (2006) Synthesis, cytotoxicity, and antiinflammatory evaluation of 2-(furan-2-yl)-4-(phenoxy)quinoline derivatives. Part 4. Bioorg Med Chem 14:4373–4378
de Souza MVN, Pais KC, Kaiser CR, Peralta MA, Ferreira ML, Lourenco MCS (2009) Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. Bioorg Med Chem Lett 17:1474–1480
Dubey A, Srivastava SK, Srivastava SD (2011) Conventional and microwave assisted synthesis of 2-oxo-4-substituted aryl-azetidine derivatives of benzotriazole: a new class of biological compounds. Bioorg Med Chem Lett 21:569–573
Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J Am Med Assoc 282:677–686
Fattorusso C, Campiani G, Kukreja G, Persico M, Butini S, Romano MP, Altarelli M, Ros S, Brindisi M, Savini L, Novellino E, Nacci V, Fattorusso E, Parapini S, Basilico N, Taramelli D, Yardley V, Croft M, Borriello S, Gemma S (2008) Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents. J Med Chem 51:1333–1343
Ferreira ML, Goncalves RSB, Cardoso LNF, Kaiser CR, Candea ALP, Henriques MGMO, Lourenco MCS, Bezerra FAFM, de Souza MVN (2010) Synthesis and antitubercular activity of heteroaromatic isonicotinoyl and 7-chloro-4-quinolinyl hydrazone derivatives. Sci World J 10:1347–1355
Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH (1998) Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36:362–366
Goto S, Jo K, Kawakita T, Mitsuhashi S, Nishino T, Ohsawa N, Tanami H (1981) Determination method of minimum inhibitory concentrations. Chemotherapy 29:76–79
Halve AK, Bhadauria D, Dubey R (2007) N/C-4 substituted azetidin-2-ones: synthesis and preliminary evaluation as new class of antimicrobial agents. Bioorg Med Chem Lett 17:341–345
He X, Alian A, Stroud R, de Montellano PRO (2006) Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase (InhA) from Mycobacterium tuberculosis. J Med Chem 49(21):6308–6323
Jain AN (1996) Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des 10:427–440
Jain AN (2003) Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem 46:499–511
Joshi SD, Vagdevi HM, Vaidya VP, Gadaginamath GS (2008) Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents. Eur J Med Chem 43:1989–1996
Joshi SD, Manish K, Badiger A (2013a) Synthesis and evaluation of antibacterial and antitubercular activities of some novel imidazo[2,1-b][1,3,4]thiadiazole derivatives. Med Chem Res 22:869–878
Joshi SD, More Y, Vagdevi HM, Vaidya VP, Gadaginamath GS, Kulkarni VH (2013b) Synthesis of new 4-(2,5-dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial, antifungal and antitubercular agents. Med Chem Res 22:1073–1089
Joshi SD, More UA, Aminabhavi TM, Badiger AM (2014a) Two and three-dimensional QSAR studies on a set of antimycobacterial pyrroles: CoMFA, Topomer CoMFA, and HQSAR. Med Chem Res 23:107–126
Joshi SD, More UA, Dixit SR, Korat HH, Aminabhavi TM, Badiger AM (2014b) Synthesis, characterization, biological activity, and 3D-QSAR studies on some novel class of pyrrole derivatives as antitubercular agents. Med Chem Res 23:1123–1147
Karal N, Gursoy A, Kandemirli F, Shvets N, Kaynak FB, Ozbey S, Kovalishyne V, Dimoglo A (2007) Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg Med Chem 15:5888–5904
Khalil MA, El-Sayed OA, El-Shamy HA (1993) Synthesis and antimicrobial evaluation of novel oxa(thia)diazolylquinolines and oxa(thia)diazepino[7,6-b] quinolines. Arch Pharm 326:489–492
Kidwai M, Bhushan KR, Sapra P, Saxena RK, Gupta R (2000) Alumina-supported synthesis of antibacterial quinolines using microwaves. Bioorg Med Chem 8:69–72
Kuethe JT, Wong A, Qu C, Smitrovich J, Davies IW, Hughes DL (2005) Synthesis of 5-substituted-1H-indol-2-yl-1H-quinolin-2-ones: a novel class of KDR kinase inhibitors. J Org Chem 70:2555–2567
Luckner SR, Liu N, am Ende CW, Tonge PJ, Kisker C (2010) A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis. J Biol Chem 285:14330–14337
Malendez Gomez CM, Kouznestsov VV, Sortino MA, Alvarez SL, Zacchino SA (2008) In vitro antifungal activity of polyfunctionalized 2-(hetero)arylquinolines prepared through imino Diels–Alder reactions. Bioorg Med Chem 16:7908–7920
Massengo-Tiasse RP, Cronan JE (2009) Diversity in enoyl-acyl carrier protein reductases. Cell Mol Life Sci 66:1507–1517
Meth-Cohn O, Narine B, Tarnowski B (1981) A versatile new synthesis of quinolines and related fused pyridines, part 5. The synthesis of 2-chloroquinoline-3-carbaldehydes. J Chem Soc Perkin Trans 1:1520–1530
Modapa S, Tusi Z, Sridhar D, Kumar A, Siddiqi MI, Srivastava K, Rizvi A, Tripathi R, Puri SK, Keshava GBS, Shukla PK, Batra S (2009) Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides. Bioorg Med Chem 17:203–221
Mol W, Matyia M, Filip B, Wietrzyk J, Boryczka S (2008) Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines. Bioorg Med Chem 16:8136–8141
More UA, Joshi SD, Aminabhavi TM, Gadad AK, Nadagoudaa MN, Kulkarni VH (2014) Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents. Eur J Med Chem 71:199–218
More UA, Joshi SD, Aminabhavi TM, Kulkarni VH, Badiger AM, Lherbet C (2015) Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: an in silico approach. Eur J Med Chem 94:317–339
National Committee for Clinical Laboratory Standards (NCCLS) (1985) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard. National Committee for Clinical Laboratory Standards, Villanova, PA
Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (2011) Carbapenems: past, present, and future. Antimicrob Agents Chemother 55:4943–4960
Quemard A, Sacchettini JC, Dessen A, Vilcheze C, Bittman R, Jacobs WR Jr, Blanchard JS (1995) Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235–8241
Rustomjee R, Diacon AH, Allen J, Venter A, Reddy C, Patientia RF, Mthiyane TCP, de Marez T, Van Heeswijk R, Kerstens R, Koul A, De Beule K, Donald PR, McNeeley DF (2008) Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis. Antimicrob Agents Chemother 52:2831–2835
Savini L, Chiasserini L, Gaeta A, Pellerano C (2002) Synthesis and anti-tubercular evaluation of 4-quinolylhydrazones. Bioorg Med Chem 10:2193–2198
Snider DE Jr (1994) Global burden of tuberculosis. In: Bloom BR (ed) Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, pp 3–59
Tripos International (2012) Sybyl-X 2.0. Tripos International, St. Louis
Veinberg S, Vorona K (2004) Synthesis of antitumor 6-alkylidenepenicillanate sulfones and related 3-alkylidene-2-azetidinones. Bioorg Med Chem 12:147–150
Acknowledgments
The authors gratefully acknowledge the financial support from the Indian Council of Medical Research, New Delhi, India (File No. 64/4/2011-BMS, IRIS Cell No. 2010-08710) and Rajiv Gandhi University of Health Sciences, Bangalore, India for a partial financial support [File No RGUHS/R&D/RG/P25/2011-12 dated 07/12/2011]. We thank Dr. V. H. Kulkarni, Principal and Mr. H. V. Dambal, President, S. E. T’s College of Pharmacy, Dharwad, India, for providing facilities. We also thank Dr. A. M. Godbole (S. E. T’s College of Pharmacy, Dharwad, India) for co-operation and Dr. K. G. Bhat (Maratha Mandal’s Dental College, Hospital and Research Centre, Belgaum, India) for providing facilities for antibacterial and antitubercular activity tests. Director, SAIF, Indian Institute of Technology, Chennai, Tamil Nadu, India and Director, USIC, Karnatak University Dharwad, India have provided NMR and mass spectral data. Dr. W.E. Rudzinski (Texas State University, San Marcos, USA) helped in mass spectral analysis. Mr. S. A. Tiwari provided the technical assistance to this project.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper is affectionately dedicated to my teacher Dr. V. H. Kulkarni for his service to Pharmacy Profession.
Rights and permissions
About this article
Cite this article
Joshi, S.D., More, U.A., Parkale, D. et al. Design, synthesis of quinolinyl Schiff bases and azetidinones as enoyl ACP-reductase inhibitors. Med Chem Res 24, 3892–3911 (2015). https://doi.org/10.1007/s00044-015-1432-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-015-1432-7